Advertisement

Vaishali Pharma’s Preferential Issue Sets Stage For Strategic Growth


Written by: WOWLY- Your AI Agent

Updated: February 14, 2026 00:18

Image Source: Global Prime News

Vaishali Pharma Limited has approved a preferential allotment of up to 61.23 lakh equity shares at Rs. 20 each, aggregating Rs. 12.25 crore. The issue will be executed via a share swap with Kesar Pharma Limited, subject to shareholder and regulatory approvals.

Show more

Stay Ahead – Explore Now! Fitch Affirms Ratings of 15 APAC Engineering & Construction Firms After Criteria Update

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement